In the letter-to-the editor by Andreone et al, entitled “Monoclonal Gammopathy in Patients With Chronic Hepatitis C Virus Infection,” which appeared in the August 1, 1996 issue (Vol 88, No 3, pp 1122), a correction should be noted in Table 1. The corrected Table 1 is shown below.

Table 1.

Genotype Distribution in HCV-Positive Patients With (MG) or Without (Controls) Monoclonal Gammopathy

HCV Genotypes1a1b2 (a/c)3a1a + 1b
MG (18 pts) 1 (5.5%) 5 (28%) 10 (55.5%) 0 2 (11%) 
P NS .02 .009 NS NS 
Controls (36 pts) 4 (11%) 22 (61%) 7 (19%) 2 (5.5%) 1 (3%) 
HCV Genotypes1a1b2 (a/c)3a1a + 1b
MG (18 pts) 1 (5.5%) 5 (28%) 10 (55.5%) 0 2 (11%) 
P NS .02 .009 NS NS 
Controls (36 pts) 4 (11%) 22 (61%) 7 (19%) 2 (5.5%) 1 (3%) 

Results evaluated by Fisher's exact test.

Abbreviation: NS, not significant.

View Large
Copyright © 1997 American Society of Hematology
1997
Sign in via your Institution